Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review.
Crit Rev Oncol Hematol. 2024 Sep 24;204:104524. doi: 10.1016/j.critrevonc.2024.104524. Online ahead of print.
Crit Rev Oncol Hematol. 2024.
PMID: 39326646
Free article.
Review.
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.
Buonaiuto R, Neola G, Caltavituro A, Longobardi A, Mangiacotti FP, Cefaliello A, Lamia MR, Pepe F, Ventriglia J, Malapelle U, Troncone G, Giuliano M, Arpino G, Pignata S, De Angelis C.
Buonaiuto R, et al. Among authors: lamia mr.
Front Oncol. 2024 Sep 9;14:1412807. doi: 10.3389/fonc.2024.1412807. eCollection 2024.
Front Oncol. 2024.
PMID: 39314634
Free PMC article.
Item in Clipboard
Cite
Cite